苯乙酰谷氨酰胺与慢性肾脏病患者认知障碍的关联
在CKD-REIN队列3033例CKD 2至5期患者中,纳入2590例有PAG测量且3个月内完成MMSE者,35%存在认知障碍(MMSE≤26/30)。校正多因素后,PAG水平每增加2倍与认知障碍相关(OR 1.12,95%CI 1.01-1.23)。作者认为需进一步研究确认因果关系并探索降低血清PAG以保护认知的策略。
要点
- 在非透析依赖性CKD成人中,较高的血清PAG水平与认知障碍相关(OR 1.12,95%CI 1.01-1.23)。
- 该横断面分析纳入2590例CKD 2至5期患者,35%存在认知障碍(MMSE≤26/30)。
- 作者指出需进一步研究确认关联的因果性,并探索降低血清PAG水平以保护认知的策略。
核心结论
- 本研究表明,在非透析依赖性CKD成人中,较高的血清PAG水平与认知障碍相关,并提示一种与CKD患者认知障碍相关的新尿毒症毒素。
- 作者指出需进一步研究确认该关联的因果性,并探索降低血清PAG水平以保护认知的策略。
研究设计与样本
- CKD-Renal Epidemiology and Information Network(CKD-REIN)队列研究纳入3033例CKD 2至5期患者。
- 本横断面分析纳入PAG测量与简易精神状态检查(MMSE)评分间隔在3个月内的患者。
- 认知障碍定义为MMSE评分≤26分(满分30分)。
- 采用逻辑回归评估PAG与认知障碍的关联。
主要发现
- 纳入2590例患者,平均(SD)年龄67(13)岁,平均(SD)估算肾小球滤过率(eGFR)34(13)ml/min per 1.73 m2,PAG水平中位数(四分位距,IQR)2.1(1.2-3.6)mg/l。
- 908例(35%)患者MMSE评分≤26分(满分30分)。
- 校正社会人口学因素(年龄、男性、教育水平)、心血管危险因素、脑血管病、当前抑郁、eGFR、尿白蛋白与肌酐比值(uACR)及已知与认知障碍风险相关的尿毒症毒素后,PAG水平每增加2倍与认知障碍相关(OR 1.12,95%CI 1.01-1.23)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Chronic kidney disease (CKD) leads to the accumulation of uremic toxins (UTs). Studies have suggested that UTs are associated with cognitive impairment (CI) in patients with CKD. Recently, studies reported that phenylacetylglutamine (PAG) contributes to the association between CKD and CI. However, this association has not been investigated in nondialysis-dependent adults with CKD. METHODS: The CKD-Renal Epidemiology and Information Network (CKD-REIN) cohort study included 3033 patients with CKD stages 2 to 5. This cross-sectional analysis included those with a PAG measurement and a mini-mental state examination (MMSE) score within 3 months of each other. CI was defined as an MMSE score ≤ 26 out of 30. Logistic regression was used to assess the association between PAG and CI. RESULTS: Of the 2590 patients included (mean [SD] age: 67 [13] years, mean [SD] estimated glomerular filtration rate [eGFR]: 34 [13] ml/min per 1.73 m2, median [interquartile range, IQR] PAG level: 2.1 [1.2-3.6] mg/l), 908 (35%) presented an MMSE score ≤ 26 out of 30. After adjustment for sociodemographic factors (age, male sex, and educational level), cardiovascular risk factors, cerebrovascular disease, current depression, eGFR, urinary albumin-to-creatinine ratio (uACR), and UTs known to be associated with CI risk, a 2-fold increase in the PAG level was associated with CI (odds ratio [OR] [95% confidence interval]: 1.12 [1.01-1.23]). CONCLUSION: This study shows that a higher serum PAG level was associated with CI in nondialysis-dependent adults with CKD and highlight a new UT associated with CI in patients with CKD. Further studies are needed to confirm the causal nature of the association and to explore strategies for reducing serum PAG levels to protect cognition.
引用
- Levassort H, Boucquemont J, Liabeuf S, et al. Association of Phenylacetylglutamine and Cognitive Impairment in CKD. Kidney Int Rep. 2025. PMID: 40814635. doi:10.1016/j.ekir.2025.05.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。